Mrozek, K., Marcucci, G., Maharry, K., Nicolet, D., Becker, H., Whitman, S. P., … Bloomfield, C. D. (2011). Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts). In BLOOD (Vol. 118, pp. 190–191). San Diego, CA: AMER SOC HEMATOLOGY.

Mrozek, Krzysztof, Guido Marcucci, Kati Maharry, Deedra Nicolet, Heiko Becker, Susan P. Whitman, Klaus H. Metzeler, et al. “Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts).” In BLOOD, 118:190–91. AMER SOC HEMATOLOGY, 2011.

Mrozek K, Marcucci G, Maharry K, Nicolet D, Becker H, Whitman SP, et al. Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts). In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 190–1.

Mrozek, Krzysztof, et al. “Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts).” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 190–91.

Mrozek K, Marcucci G, Maharry K, Nicolet D, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu Y-Z, Kohlschmidt J, Pettenati MJ, Koduru PRK, Heerema NA, Block AW, Patil SR, Baer MR, Kolitz JE, Moore JO, Carroll AJ, Larson RA, Bloomfield CD. Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts). BLOOD. AMER SOC HEMATOLOGY; 2011. p. 190–191.